Sfoglia per Autore
Long-Term Follow-up in Very Elderly Patients with Chronic Myeloid Leukemia Treated with Imatinib Frontline
2015-01-01 Latagliata, R; Breccia, M; Ferrero, D; Cavazzini, F; Trawinska, Mm; Castagnetti, F; Annunziata, M; Stagno, F; Tiribelli, M; Binotto, G; Fava, C; Crisa, E; Mansueto, G; Gozzini, A; Falzetti, F; Montefusco, E; Iurlo, A; Sabina, R; Cedrone, M; Rossi, Ar; Gugliotta, G; Pregno, P; Isidori, A; Avanzini, P; Endri, M; Romano, A; Giglio, G; Celesti, F; Sora, F; Storti, S; D'Addosio, A; Galimberti, S; Orlandi, Em; Calistri, E; Bocchia, M; Crugnola, M; Cambrin, Gr; Vigneri, P; Luciano, L; Abruzzese, E; Alimena, G
Hematopoietic stem and progenitor cell composition in peripheral blood and in mobilized CD34+ cells harvests.
2015-01-01 Valentina Giai; Elona Saraci; Eleonora Marzanati; Christian Scharenberg; Paola Omedè; Eva Hellström-Lindberg; Antonio Palumbo; Benedetto Bruno; Mario Boccadoro; Dario Ferrero
Differences among young adults, adults and elderly chronic myeloid leukemia patients.
2015-01-01 Castagnetti, F; Gugliotta, G; Baccarani, M; Breccia, M; Specchia, G; Levato, L; Abruzzese, E; Rossi, G; Iurlo, A; Martino, B; Pregno, P; Stagno, F; Cuneo, A; Bonifacio, M; Gobbi, M; Russo, D; Gozzini, A; Tiribelli, M; de Vivo, A; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Rosti, G; Gimema, CML Working Party including Salvi F; Pini, M; Leoni, P; Rupoli, S; Galieni, P; Bigazzi, C; Cantore, N; Palmieri, F; Albano, F; Russo Rossi, A; Rambaldi, A; Intermesoli, T; Palandri, F; Testoni, N; Luatti, S; Soverini, S; Iacobucci, I; Bochicchio, Mt; Apolinari, M; Fogli, M; Cervello, I; Capucci, A; Malagola, M; Malpignano, A; Girasoli, M; Angelucci, E; Usala, E; Storti, S; De Biasi, E; Tagariello, G; Sartori, R; Di Raimondo, F; Vigneri, P; Impera, S; Molica, S; Lanza, F; Viganò, C; Grasso, M; Rapezzi, D; Cavazzini, F; Bosi, A; Santini, V; Capalbo, Sf; Spinosa, G; Pierri, I; Bergamaschi, M; Carella, Am; Bacigalupo, A; De Blasio, A; Ciccone, F; Di Renzo, N; Musolino, C; Russo, S; Cortelezzi, A; Morra, E; Pungolino, Em; Luppi, M; Marasca, R; Pogliani, Em; Gambacorti-Passerini, C; Luciano, L; Ferrara, F; Annunziata, M; Latte, G; Noli, D; Rege-Cambrin, G; Fava, C; Semenzato, G; Binotto, G; Fabbiano, F; Turri, D; Siragusa, S; Caracciolo, C; Musso, M; Porretto, F; Aversa, F; Crugnola, M; Cazzola, M; Orlandi, E; Falini, B; Falzetti, F; Visani, G; Isidori, A; Fioritoni, G; Di Lorenzo, R; Vallisa, D; Trabacchi, E; Petrini, M; Galimberti, S; Pizzuti, M; Zaccaria, A; Salvucci, M; Ronco, F; Ielo, D; Merli, F; Avanzini, P; Tosi, P; Merli, A; Musto, P; De Stefano, V; Sica, S; Latagliata, R; De Fabritiis, P; Trawiska, M; Majolino, I; Pacilli, L; Ronci, B; Cedrone, M; Petti, Mc; Pisani, F; Tafuri, A; Montefusco, E; Iuliano, F; Dore, F; Pardini, S; Bocchia, M; Defina, M; Liberati, Am; Luzzi, D; Boccadoro, M; Ferrero, D; Vitolo, U; Gherlinzoni, F; Calistri, E; Fanin, R; Pizzolo, G; Meneghini, V; Rodighiero, F; D'Emilio, A
VERY ELDERLY CP-CML PATIENTS TREATED WITH IMATINIB FRONTLINE: HAVE CONCOMITANT THERAPIES AN IMPACT ON OUTCOME AND TOXICITY?
2015-01-01 Iurlo, A; Latagliata, R; Bucelli, C; Ferrero, D; Castagnetti, F; Breccia, M; Abruzzese, E; Fava, C; Annunziata, M; Stagno, F; Vigneri, P; Tiribelli, M; Cavazzini, F; Binotto, G; Mansueto, G; Gozzini, A; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Cattaneo, D; Djade, Cd; Cedrone, M; Rossi, Ar; Avanzini, P; Pregno, P; Mauro, E; Endri, M; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Sica, S; Storti, S; D'Addosio, A; Rege-Cambrin, G; Luciano, L; Saglio, G; Rosti, G; Alimena, G; Nobili, A; Cortelezzi, A
IMATINIB DISCOTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON 28 UNSELECTED PATIENTS
2014-01-01 Cerrano, M; Fava, C; Pregno, P; Giai, V; Nicolosi, M; Aguzzi, C; Dogliotti, I; Rege-Cambrin, G; Boccadoro, M; Vitolo, U; Saglio, G; Ferrero, D
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.
2014-01-01 Ferrero D;Crisà E;Marmont F;Audisio E;Frairia C;Giai V;Gatti T;Festuccia M;Bruno B;Riera L;Passera R;Boccadoro M
In patients with Polycythemia Vera older age is the prognostic factor at highest impact on survival
2014-01-01 Benevolo, G; Nicolino, B; Crisà, E; Pregno, P; Evangelista, A; Pirillo, F; D’Antico, S; Pich, Achille; Ferrero, Dario; Vitolo, U.
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival.
2014-01-01 Breccia M; Luciano L; Latagliata R; Castagnetti F; Ferrero D; Cavazzini F; Trawinska MM; Annunziata M; Stagno F; Tiribelli M; Binotto G; Crisà E; Musto P; Gozzini A; Cavalli L; Montefusco E; Iurlo A; Russo S; Cedrone M; Rossi AR; Pregno P; Endri M; Spadea A; Molica M; Giglio G; Celesti F; Sorà F; Storti S; D'Addosio A; Cambrin GR; Isidori A; Sica S; Abruzzese E; Speccha G; Rosti G; Alimena G.
A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS
2014-01-01 Dario Ferrero; Elena Crisà; Filippo Marmont; Ernesta Audisio; Chiara Frairia; Valentina Giai; Tiziana Gatti; Moreno Festuccia; Benedetto Bruno; Ludovica Riera; Roberto Passera; Mario Boccadoro
ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA
2013-01-01 Bruno Benedetto; Audisio E; D'Ardia ; Ferrero ; Maffini ; Giaccone Luisa; Allione; Busca; Della Casa; Testa; Frairia; Ferrando; Festuccia ; Brunello; Evangelista ; Boccadoro Mario; Vitolo; Ciccone; Falda; Marmont
Clinical significance of early molecular response in chronic myeloid leukemia patients treated frontline with imatinib mesylate.
2013-01-01 F Castagnetti; G Gugliotta; M Breccia; F Albano; E Abruzzese; L Levato; F Cavazzini; A Iurlo; F Stagno; D Ferrero; F Porretto; B Martino; S Rupoli; T Intermesoli; C Fava; I Pierri; F Palandri; C Venturi; S Soverini; S Luatti; G Alimena; F Pane; G Martinelli; G Saglio; M Cavo; M Baccarani; G Rosti.
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study.
2013-01-01 Latagliata R; Ferrero D; Iurlo A; Cavazzini F; Castagnetti F; Abruzzese E; Fava C; Breccia M; Annunziata M; Stagno F; Tiribelli M; Binotto G; Mansueto G; Gozzini A; Russo S; Cavalli L; Montefusco E; Gugliotta G; Cedrone M; Russo Rossi A; Avanzini P; Pregno P; Mauro E; Spadea A; Celesti F; Giglio G; Isidori A; Crugnola M; Calistri E; Sorà F; Storti S; D'Addosio A; Rege-Cambrin G; Luciano L; Alimena G.
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
2013-01-01 Santini V; Schemenau J; Levis A; Balleari E; Sapena R; Adès L; Guerci A; Beyne-Rauzy O; Gourin MP; Cheze S; Stamatoullas A; Sanna A; Gioia D; Cametti G; Ferrero D; Raffoux E; Rose C; Poloni A; Prebet T; Legros L; Natarajan-Amé S; Fenaux P; Germing U; Dreyfus F; Park S.
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.
2013-01-01 Latagliata R; Breccia M; Fava C; Stagno F; Tiribelli M; Luciano L; Gozzini A; Gugliotta G; Annunziata M; Cavazzini F; Ferrero D; Musto P; Capodanno I; Iurlo A; Visani G; Crugnola M; Calistri E; Castagnetti F; Vigneri P; Alimena G.
Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early treatment modifications in suboptimal responders: a retrospective study on 91 unselected patients.
2013-01-01 Cerrano M; Crisà E; Pregno P; Aguzzi C; Riccomagno P; Boccadoro M; Ferrero D.
ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA
2013-01-01 Bruno B; Audisio E; D'Ardia S; Ferrero D; Maffini E; Giaccone L; Allione D; Busca A; Della Casa C; Testa F; Frairia C; Ferrando F; Festuccia M; Brunello L; Evangelista A; Boccadoro M; Vitolo U; Ciccone G; Falda M and Marmont F
A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience.
2012-01-01 Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P.
A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib.
2012-01-01 Dario Ferrero; Elena Crisà; Marco Cerrano; Mario Boccadoro; Francesca Pirillo; Maura Nicolosi; Umberto Vitolo; Giovanna Rege Cambrin; Carmen Fava; Giuseppe Saglio; Monia Lunghi; Gioacchino Catania; Alessandro Levis; and Patrizia Pregno.
Azacitidine for the treatment of patients with acute myeloid leukemia : Report of 82 patients enrolled in an Italian compassionate program
2012-01-01 Maurillo L; Venditti A; Spagnoli A; Gaidano G; Ferrero D; Oliva E; Lunghi M; D'Arco AM; Levis A; Pastore D; Di Renzo N; Santagostino A; Pavone V; Buccisano F; Musto P.
The BCR-ABL Transcript Levels At 3 and 6 Months Predict the Long-Term Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Imatinib Mesylate: A Gimema CML WP Analysis.
2012-01-01 Fausto Castagnetti; Gabriele Gugliotta; Massimo Breccia; Giorgina Specchia; Elisabetta Abruzzese; Luciano Levato; Francesco Cavazzini; Alessandra Iurlo; Fabio Stagno; Dario Ferrero; Ferdinando Porretto; Bruno Martino; Serena Rupoli; Tamara Intermesoli; Carmen Fava; Francesca Palandri; Claudia Venturi; Simona Soverini; Nicoletta Testoni; Giuliana Alimena; Fabrizio Pane; Giuseppe Saglio; Giovanni Martinelli; Michele Baccarani; and Gianantonio Rosti.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Long-Term Follow-up in Very Elderly Patients with Chronic Myeloid Leukemia Treated with Imatinib Frontline | 2015 | Latagliata, R; Breccia, M; Ferrero, D; Cavazzini, F; Trawinska, Mm; Castagnetti, F; Annunziata, M; Stagno, F; Tiribelli, M; Binotto, G; Fava, C; Crisa, E; Mansueto, G; Gozzini, A; Falzetti, F; Montefusco, E; Iurlo, A; Sabina, R; Cedrone, M; Rossi, Ar; Gugliotta, G; Pregno, P; Isidori, A; Avanzini, P; Endri, M; Romano, A; Giglio, G; Celesti, F; Sora, F; Storti, S; D'Addosio, A; Galimberti, S; Orlandi, Em; Calistri, E; Bocchia, M; Crugnola, M; Cambrin, Gr; Vigneri, P; Luciano, L; Abruzzese, E; Alimena, G | |
| Hematopoietic stem and progenitor cell composition in peripheral blood and in mobilized CD34+ cells harvests. | 2015 | Valentina Giai; Elona Saraci; Eleonora Marzanati; Christian Scharenberg; Paola Omedè; Eva Hellström-Lindberg; Antonio Palumbo; Benedetto Bruno; Mario Boccadoro; Dario Ferrero | |
| Differences among young adults, adults and elderly chronic myeloid leukemia patients. | 2015 | Castagnetti, F; Gugliotta, G; Baccarani, M; Breccia, M; Specchia, G; Levato, L; Abruzzese, E; Rossi, G; Iurlo, A; Martino, B; Pregno, P; Stagno, F; Cuneo, A; Bonifacio, M; Gobbi, M; Russo, D; Gozzini, A; Tiribelli, M; de Vivo, A; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Rosti, G; Gimema, CML Working Party including Salvi F; Pini, M; Leoni, P; Rupoli, S; Galieni, P; Bigazzi, C; Cantore, N; Palmieri, F; Albano, F; Russo Rossi, A; Rambaldi, A; Intermesoli, T; Palandri, F; Testoni, N; Luatti, S; Soverini, S; Iacobucci, I; Bochicchio, Mt; Apolinari, M; Fogli, M; Cervello, I; Capucci, A; Malagola, M; Malpignano, A; Girasoli, M; Angelucci, E; Usala, E; Storti, S; De Biasi, E; Tagariello, G; Sartori, R; Di Raimondo, F; Vigneri, P; Impera, S; Molica, S; Lanza, F; Viganò, C; Grasso, M; Rapezzi, D; Cavazzini, F; Bosi, A; Santini, V; Capalbo, Sf; Spinosa, G; Pierri, I; Bergamaschi, M; Carella, Am; Bacigalupo, A; De Blasio, A; Ciccone, F; Di Renzo, N; Musolino, C; Russo, S; Cortelezzi, A; Morra, E; Pungolino, Em; Luppi, M; Marasca, R; Pogliani, Em; Gambacorti-Passerini, C; Luciano, L; Ferrara, F; Annunziata, M; Latte, G; Noli, D; Rege-Cambrin, G; Fava, C; Semenzato, G; Binotto, G; Fabbiano, F; Turri, D; Siragusa, S; Caracciolo, C; Musso, M; Porretto, F; Aversa, F; Crugnola, M; Cazzola, M; Orlandi, E; Falini, B; Falzetti, F; Visani, G; Isidori, A; Fioritoni, G; Di Lorenzo, R; Vallisa, D; Trabacchi, E; Petrini, M; Galimberti, S; Pizzuti, M; Zaccaria, A; Salvucci, M; Ronco, F; Ielo, D; Merli, F; Avanzini, P; Tosi, P; Merli, A; Musto, P; De Stefano, V; Sica, S; Latagliata, R; De Fabritiis, P; Trawiska, M; Majolino, I; Pacilli, L; Ronci, B; Cedrone, M; Petti, Mc; Pisani, F; Tafuri, A; Montefusco, E; Iuliano, F; Dore, F; Pardini, S; Bocchia, M; Defina, M; Liberati, Am; Luzzi, D; Boccadoro, M; Ferrero, D; Vitolo, U; Gherlinzoni, F; Calistri, E; Fanin, R; Pizzolo, G; Meneghini, V; Rodighiero, F; D'Emilio, A | |
| VERY ELDERLY CP-CML PATIENTS TREATED WITH IMATINIB FRONTLINE: HAVE CONCOMITANT THERAPIES AN IMPACT ON OUTCOME AND TOXICITY? | 2015 | Iurlo, A; Latagliata, R; Bucelli, C; Ferrero, D; Castagnetti, F; Breccia, M; Abruzzese, E; Fava, C; Annunziata, M; Stagno, F; Vigneri, P; Tiribelli, M; Cavazzini, F; Binotto, G; Mansueto, G; Gozzini, A; Russo, S; Falzetti, F; Montefusco, E; Gugliotta, G; Cattaneo, D; Djade, Cd; Cedrone, M; Rossi, Ar; Avanzini, P; Pregno, P; Mauro, E; Endri, M; Spadea, A; Celesti, F; Giglio, G; Isidori, A; Crugnola, M; Calistri, E; Sora, F; Sica, S; Storti, S; D'Addosio, A; Rege-Cambrin, G; Luciano, L; Saglio, G; Rosti, G; Alimena, G; Nobili, A; Cortelezzi, A | |
| IMATINIB DISCOTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON 28 UNSELECTED PATIENTS | 2014 | Cerrano, M; Fava, C; Pregno, P; Giai, V; Nicolosi, M; Aguzzi, C; Dogliotti, I; Rege-Cambrin, G; Boccadoro, M; Vitolo, U; Saglio, G; Ferrero, D | |
| Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents. | 2014 | Ferrero D;Crisà E;Marmont F;Audisio E;Frairia C;Giai V;Gatti T;Festuccia M;Bruno B;Riera L;Passera R;Boccadoro M | |
| In patients with Polycythemia Vera older age is the prognostic factor at highest impact on survival | 2014 | Benevolo, G; Nicolino, B; Crisà, E; Pregno, P; Evangelista, A; Pirillo, F; D’Antico, S; Pich, Achille; Ferrero, Dario; Vitolo, U. | |
| Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival. | 2014 | Breccia M; Luciano L; Latagliata R; Castagnetti F; Ferrero D; Cavazzini F; Trawinska MM; Annunziata M; Stagno F; Tiribelli M; Binotto G; Crisà E; Musto P; Gozzini A; Cavalli L; Montefusco E; Iurlo A; Russo S; Cedrone M; Rossi AR; Pregno P; Endri M; Spadea A; Molica M; Giglio G; Celesti F; Sorà F; Storti S; D'Addosio A; Cambrin GR; Isidori A; Sica S; Abruzzese E; Speccha G; Rosti G; Alimena G. | |
| A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS | 2014 | Dario Ferrero; Elena Crisà; Filippo Marmont; Ernesta Audisio; Chiara Frairia; Valentina Giai; Tiziana Gatti; Moreno Festuccia; Benedetto Bruno; Ludovica Riera; Roberto Passera; Mario Boccadoro | |
| ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA | 2013 | Bruno Benedetto; Audisio E; D'Ardia ; Ferrero ; Maffini ; Giaccone Luisa; Allione; Busca; Della Casa; Testa; Frairia; Ferrando; Festuccia ; Brunello; Evangelista ; Boccadoro Mario; Vitolo; Ciccone; Falda; Marmont | |
| Clinical significance of early molecular response in chronic myeloid leukemia patients treated frontline with imatinib mesylate. | 2013 | F Castagnetti; G Gugliotta; M Breccia; F Albano; E Abruzzese; L Levato; F Cavazzini; A Iurlo; F Stagno; D Ferrero; F Porretto; B Martino; S Rupoli; T Intermesoli; C Fava; I Pierri; F Palandri; C Venturi; S Soverini; S Luatti; G Alimena; F Pane; G Martinelli; G Saglio; M Cavo; M Baccarani; G Rosti. | |
| Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study. | 2013 | Latagliata R; Ferrero D; Iurlo A; Cavazzini F; Castagnetti F; Abruzzese E; Fava C; Breccia M; Annunziata M; Stagno F; Tiribelli M; Binotto G; Mansueto G; Gozzini A; Russo S; Cavalli L; Montefusco E; Gugliotta G; Cedrone M; Russo Rossi A; Avanzini P; Pregno P; Mauro E; Spadea A; Celesti F; Giglio G; Isidori A; Crugnola M; Calistri E; Sorà F; Storti S; D'Addosio A; Rege-Cambrin G; Luciano L; Alimena G. | |
| Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS? | 2013 | Santini V; Schemenau J; Levis A; Balleari E; Sapena R; Adès L; Guerci A; Beyne-Rauzy O; Gourin MP; Cheze S; Stamatoullas A; Sanna A; Gioia D; Cametti G; Ferrero D; Raffoux E; Rose C; Poloni A; Prebet T; Legros L; Natarajan-Amé S; Fenaux P; Germing U; Dreyfus F; Park S. | |
| Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia. | 2013 | Latagliata R; Breccia M; Fava C; Stagno F; Tiribelli M; Luciano L; Gozzini A; Gugliotta G; Annunziata M; Cavazzini F; Ferrero D; Musto P; Capodanno I; Iurlo A; Visani G; Crugnola M; Calistri E; Castagnetti F; Vigneri P; Alimena G. | |
| Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early treatment modifications in suboptimal responders: a retrospective study on 91 unselected patients. | 2013 | Cerrano M; Crisà E; Pregno P; Aguzzi C; Riccomagno P; Boccadoro M; Ferrero D. | |
| ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA | 2013 | Bruno B; Audisio E; D'Ardia S; Ferrero D; Maffini E; Giaccone L; Allione D; Busca A; Della Casa C; Testa F; Frairia C; Ferrando F; Festuccia M; Brunello L; Evangelista A; Boccadoro M; Vitolo U; Ciccone G; Falda M and Marmont F | |
| A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience. | 2012 | Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P. | |
| A Retrospective Real-Life Analysis of Chronic Myeloid Leukemia Patients in Suboptimal Response to Imatinib. | 2012 | Dario Ferrero; Elena Crisà; Marco Cerrano; Mario Boccadoro; Francesca Pirillo; Maura Nicolosi; Umberto Vitolo; Giovanna Rege Cambrin; Carmen Fava; Giuseppe Saglio; Monia Lunghi; Gioacchino Catania; Alessandro Levis; and Patrizia Pregno. | |
| Azacitidine for the treatment of patients with acute myeloid leukemia : Report of 82 patients enrolled in an Italian compassionate program | 2012 | Maurillo L; Venditti A; Spagnoli A; Gaidano G; Ferrero D; Oliva E; Lunghi M; D'Arco AM; Levis A; Pastore D; Di Renzo N; Santagostino A; Pavone V; Buccisano F; Musto P. | |
| The BCR-ABL Transcript Levels At 3 and 6 Months Predict the Long-Term Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Imatinib Mesylate: A Gimema CML WP Analysis. | 2012 | Fausto Castagnetti; Gabriele Gugliotta; Massimo Breccia; Giorgina Specchia; Elisabetta Abruzzese; Luciano Levato; Francesco Cavazzini; Alessandra Iurlo; Fabio Stagno; Dario Ferrero; Ferdinando Porretto; Bruno Martino; Serena Rupoli; Tamara Intermesoli; Carmen Fava; Francesca Palandri; Claudia Venturi; Simona Soverini; Nicoletta Testoni; Giuliana Alimena; Fabrizio Pane; Giuseppe Saglio; Giovanni Martinelli; Michele Baccarani; and Gianantonio Rosti. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile